120 related articles for article (PubMed ID: 9722080)
1. Myasthenia gravis post allogeneic bone marrow transplantation revisited.
Koski SL; Mackey JR; Mackey DS
Bone Marrow Transplant; 1998 Aug; 22(4):403-4. PubMed ID: 9722080
[No Abstract] [Full Text] [Related]
2. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations.
Grau JM; Casademont J; Monforte R; Marín P; Grañena A; Rozman C; Urbano-Márquez A
Bone Marrow Transplant; 1990 Jun; 5(6):435-7. PubMed ID: 2369684
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease.
Tse S; Saunders EF; Silverman E; Vajsar J; Becker L; Meaney B
Bone Marrow Transplant; 1999 Feb; 23(4):397-9. PubMed ID: 10100585
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature.
Mackey JR; Desai S; Larratt L; Cwik V; Nabholtz JM
Bone Marrow Transplant; 1997 May; 19(9):939-42. PubMed ID: 9156270
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific kinase antibody associated myasthenia gravis after bone marrow transplantation.
Heidarzadeh Z; Mousavi SA; Ostovan VR; Nafissi S
Neuromuscul Disord; 2014 Feb; 24(2):148-50. PubMed ID: 24314584
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia gravis after bone-marrow transplantation. Evidence for a donor origin.
Smith CI; Aarli JA; Biberfeld P; Bolme P; Christensson B; Gahrton G; Hammarström L; Lefvert AK; Lönnqvist B; Matell G
N Engl J Med; 1983 Dec; 309(25):1565-8. PubMed ID: 6361555
[No Abstract] [Full Text] [Related]
7. Contrast media triggering cutaneous graft-versus-host disease.
Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
[TBL] [Abstract][Full Text] [Related]
8. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia.
Tomonari A; Tojo A; Adachi D; Iseki T; Ooi J; Shirafuji N; Tani K; Asano S
Ann Hematol; 2003 Jan; 82(1):37-40. PubMed ID: 12574963
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
10. Massive hematochezia secondary to graft-versus-host disease and cytomegalovirus.
Shabahang M; Pasquale MD; Bitterman P; Cirenza E; Spitzer T; Evans SR
Am J Gastroenterol; 1994 Apr; 89(4):632-3. PubMed ID: 8147374
[No Abstract] [Full Text] [Related]
11. Myasthenia gravis after allogeneic bone marrow transplantation: a case report.
Zaja F; Russo D; Silvestri F; Barillari G; Fanin R; Cerno M; Marchini C; Baccarani M
Bone Marrow Transplant; 1995 Apr; 15(4):649-50. PubMed ID: 7655397
[No Abstract] [Full Text] [Related]
12. Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies.
Malladi RK; Peniket AJ; Norton AE; Campbell AJ; Collins GP; Samol J; Eagleton H; Miller E; Morgenstern G; Jones J; Keen-Mcguire A; Barnardo M; Littlewood TJ
Eur J Haematol; 2004 Aug; 73(2):85-92. PubMed ID: 15245506
[TBL] [Abstract][Full Text] [Related]
13. [A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis].
Yanagihara C; Nakaji K; Tanaka Y; Yabe H; Nishimura Y
Rinsho Shinkeigaku; 2001 Aug; 41(8):503-6. PubMed ID: 11889835
[TBL] [Abstract][Full Text] [Related]
14. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience.
Sierra J; Storer B; Hansen JA; Martin PJ; Petersdorf EW; Woolfrey A; Matthews D; Sanders JE; Storb R; Appelbaum FR; Anasetti C
Bone Marrow Transplant; 2000 Aug; 26(4):397-404. PubMed ID: 10982286
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma.
Dowell JE; Moots PL; Stein RS
Bone Marrow Transplant; 1999 Dec; 24(12):1359-61. PubMed ID: 10627649
[TBL] [Abstract][Full Text] [Related]
16. [Results of allogeneic bone marrow transplantation in leukemia].
Yoshikawa S; Tahara T; Sao H; Yamauchi T; Yoshikawa H; Matsuyama K; Hiraiwa A; Akao Y; Morishima Y; Kodera Y
Rinsho Ketsueki; 1985 Jul; 26(7):1104-12. PubMed ID: 3903257
[No Abstract] [Full Text] [Related]
17. Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation.
Nicolini B; Balduzzi A; Tagliabue A; Longoni D; Uderzo C; Galli MA
Bone Marrow Transplant; 2000 Feb; 25(3):335-6. PubMed ID: 10673709
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
19. Disseminated zygomycosis post allogeneic bone marrow transplantation.
Kannan K; Ur-Rehman J; Rao TV; Jain R; Dennison D
Am J Hematol; 2005 May; 79(1):68-9. PubMed ID: 15849768
[No Abstract] [Full Text] [Related]
20. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia.
Chiang KY; Van Rhee F; Godder K; Bridges K; Adams S; Mehta J; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Mar; 27(5):507-10. PubMed ID: 11313684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
